Literature DB >> 18447713

Chemokine detection in the cerebral tissue of patients with posttraumatic brain contusions.

Roberto Stefini1, Emanuela Catenacci, Simone Piva, Silvano Sozzani, Alessandra Valerio, Riccardo Bergomi, Marco Cenzato, Pietro Mortini, Nicola Latronico.   

Abstract

OBJECT: The clinical outcome of patients with severe head injuries is still critically dependent on their secondary injuries. Although hypoxia and hypotension appear to mediate a substantial proportion of secondary injuries, many studies associate secondary brain injury with neuroinflammatory responses. Chemokines have been detected in the cerebrospinal fluid but not in the brain tissue of patients with head trauma. This study was performed to determine if chemokines were expressed in pericontusional brain tissue in patients with moderate or severe head trauma who underwent surgical evacuation of their brain contusions.
METHODS: Twelve patients with posttraumatic cerebral contusion requiring a surgical evacuation were studied. A 20- to 40-mg sample of white matter was removed from the surgical cavity in the pericontusional area. Two patients undergoing elective surgery for clip ligation of an unruptured aneurysm were used as controls. The median interval from trauma to biopsy procedure was 44 hours (range 3-360 hours). Total RNA was isolated from these samples and a ribonuclease protection assay was performed to measure the mRNA levels of several chemokines: CCL2, CCL3, CCL4, CCL5, CXCL8, CXCL10, and XCL1.
RESULTS: The CCL2, a monocyte chemoattractant produced by activated astrocytes, was the most strongly expressed chemokine, followed by CXCL8, CCL3, and CCL4. The chemokines CXCL10 and CCL5 were expressed at very low levels, and XCL1 was not detected.
CONCLUSIONS: Chemokine activation occurs early after moderate or severe head trauma and is maintained for several days after trauma. This event may contribute to neuroinflammatory exacerbation of posttraumatic brain damage in the pericontusional brain tissue.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18447713     DOI: 10.3171/JNS/2008/108/5/0958

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  23 in total

1.  Expression analysis of the early chemokine response 4 h after in vitro traumatic brain injury.

Authors:  Astrid V Fahlenkamp; Mark Coburn; Michael Czaplik; Yu-Mi Ryang; Markus Kipp; Rolf Rossaint; Cordian Beyer
Journal:  Inflamm Res       Date:  2010-11-23       Impact factor: 4.575

Review 2.  What has inflammation to do with traumatic brain injury?

Authors:  David Cederberg; Peter Siesjö
Journal:  Childs Nerv Syst       Date:  2009-11-26       Impact factor: 1.475

3.  Altered hippocampal synaptic transmission in transgenic mice with astrocyte-targeted enhanced CCL2 expression.

Authors:  Thomas E Nelson; Christine Hao; Jessica Manos; R M Ransohoff; Donna L Gruol
Journal:  Brain Behav Immun       Date:  2011-02-26       Impact factor: 7.217

Review 4.  The far-reaching scope of neuroinflammation after traumatic brain injury.

Authors:  Dennis W Simon; Mandy J McGeachy; Hülya Bayır; Robert S B Clark; David J Loane; Patrick M Kochanek
Journal:  Nat Rev Neurol       Date:  2017-02-10       Impact factor: 42.937

Review 5.  Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines.

Authors:  Stefka Gyoneva; Richard M Ransohoff
Journal:  Trends Pharmacol Sci       Date:  2015-05-13       Impact factor: 14.819

6.  Hypobaric hypoxia exacerbates the neuroinflammatory response to traumatic brain injury.

Authors:  Michael D Goodman; Amy T Makley; Nathan L Huber; Callisia N Clarke; Lou Ann W Friend; Rebecca M Schuster; Stephanie R Bailey; Stephen L Barnes; Warren C Dorlac; Jay A Johannigman; Alex B Lentsch; Timothy A Pritts
Journal:  J Surg Res       Date:  2010-06-16       Impact factor: 2.192

7.  Elevated plasma MCP-1 concentration following traumatic brain injury as a potential "predisposition" factor associated with an increased risk for subsequent development of Alzheimer's disease.

Authors:  Lap Ho; Wei Zhao; Kristen Dams-O'Connor; Cheuk Y Tang; Wayne Gordon; Elaine R Peskind; Shrishailam Yemul; Vahram Haroutunian; Giulio Maria Pasinetti
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

8.  Hemorrhagic shock shifts the serum cytokine profile from pro- to anti-inflammatory after experimental traumatic brain injury in mice.

Authors:  Steven L Shein; David K Shellington; Jennifer L Exo; Travis C Jackson; Stephen R Wisniewski; Edwin K Jackson; Vincent A Vagni; Hülya Bayır; Robert S B Clark; C Edward Dixon; Keri L Janesko-Feldman; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2014-08-15       Impact factor: 5.269

Review 9.  Traumatic brain injury and aeromedical evacuation: when is the brain fit to fly?

Authors:  Michael D Goodman; Amy T Makley; Alex B Lentsch; Stephen L Barnes; Gina R Dorlac; Warren C Dorlac; Jay A Johannigman; Timothy A Pritts
Journal:  J Surg Res       Date:  2009-08-26       Impact factor: 2.192

10.  Local and systemic chemokine patterns in a human musculoskeletal trauma model.

Authors:  Daniel Bastian; Margareth Vislie Tamburstuen; Ståle Petter Lyngstadaas; Olav Reikerås
Journal:  Inflamm Res       Date:  2009-03-10       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.